<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156737">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01059292</url>
  </required_header>
  <id_info>
    <org_study_id>jia123456</org_study_id>
    <nct_id>NCT01059292</nct_id>
  </id_info>
  <brief_title>TIPE2 Associated With Kidney Transplant</brief_title>
  <acronym>TIPE2</acronym>
  <official_title>Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Science Center of Xi’an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Health Science Center of Xi’an Jiaotong University</source>
  <brief_summary>
    <textblock>
      TIPE2, a negative regulator of innate and adaptive immunity that maintains immune
      homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss
      and gives rise to the immune dysfunction in renal transplant patients.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>October 2009</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">93</enrollment>
  <condition>Renal Transplant</condition>
  <eligibility>
    <study_pop>
      <textblock>
        kidney transplant patients and healty Volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  long-term surival(&gt;5year),AR and CR kidney transplant patients and healty Volunteers
             as control

        Exclusion Criteria:

          -  without hepatitis , tumor and infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2009</verification_date>
  <lastchanged_date>January 28, 2010</lastchanged_date>
  <firstreceived_date>January 28, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University</name_title>
    <organization>Xi'an Jiaotong University</organization>
  </responsible_party>
  <keyword>we have complieted party research</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
